Odwala masauzande ambiri omwe adayamba tsiku ndi tsiku Saxenda akufunsanso funso lomwelo: kodi ndi nthawi yosamukira ku Wegovy kamodzi pamlungu, ndipo kusinthaku kumayenera kuchitika bwanji mosamala? Mankhwala onsewa ndi ma GLP-1 receptor agonists opangidwa ndi Novo Nordisk, koma amagwiritsa ntchito mamolekyu osiyanasiyana (liraglutide vs semaglutide), ma rhythm osiyanasiyana komanso ma ndandanda osiyanasiyana. Kuchita bwino kumateteza kulekerera, kumachepetsa kuchepa thupi komanso kupewa zolakwika zomwe zimachitika nthawi zambiri monga kuphatikiza mankhwala awiriwa.
Ngati mukufuna kuyang'ana m'mutu kuti ndi mankhwala ati omwe akuyenera wodwala, onani kalozera wathu wakale, Kuyerekeza Wegovy ndi Saxenda: Ndi Mankhwala Ati Ochepetsa Kuwonda Ndi Oyenera Kwa Inu . Nkhaniyi ikuyang'ana pa chinthu china chosiyana: njira yeniyeni yosinthira kuchokera ku Saxenda kupita ku Wegovy, kuphimba nthawi, mlingo woyambira, titration ndi zomwe odwala ndi zipatala ayenera kuyembekezera m'miyezi yoyamba.
Chifukwa Chake Odwala Amasintha Kuchokera ku Saxenda kupita ku Wegovy
Zifukwa zomwe achipatala amaganizira kusintha kwa Saxenda kupita ku Wegovy ndi:
Kuonda kwakukulu kwapakati. Muyeso la STEP 8, akuluakulu omwe alibe matenda a shuga adataya 15.8% ya kulemera kwa thupi pa semaglutide 2.4 mg sabata iliyonse motsutsana ndi 6.4% pa liraglutide 3.0 mg tsiku lililonse pa masabata 68 (Rubino et al., JAMA 2022).
Majekeseni ochepa. Jekeseni mmodzi pa sabata m'malo mwa asanu ndi awiri amapangitsa kuti anthu ambiri asamamatire mosavuta.
Chigwa cha Saxenda. Chizindikiro cha Saxenda chimalangiza kusiya chithandizo ngati munthu wamkulu sanataye osachepera 4% ya kulemera koyambirira pambuyo pa masabata 16, zomwe zimapangitsa kuti olemba ambiri ayang'ane njira zina.
Kupereka, mtengo kapena kusintha kwa inshuwaransi , zomwe zimasiyana malinga ndi dziko ndikusintha pafupipafupi.
Kusintha sikokakamizidwa. Upangiri waku US Veterans Affairs wosinthika umati palibe chifukwa chosinthira wodwala yemwe akuchita bwino ndikuchepetsa thupi pa liraglutide. Chisankho chiyenera kukhala cha munthu payekha.
Saxenda vs Wegovy Dosing pang'ono
Malinga ndi chidziwitso chovomerezeka cha US:
Saxenda (liraglutide) amabayidwa pansi pa khungu kamodzi patsiku . Imayamba pa 0.6 mg pa tsiku kwa sabata imodzi ndipo imakwera ndi 0.6 mg mlungu uliwonse (1.2 mg, 1.8 mg, 2.4 mg) mpaka 3 mg tsiku ndi tsiku mlingo wokonza umafika pa sabata 5. Mlingo wochepa ndi wa titration okha.
Jakisoni wa Wegovy (semaglutide) amaperekedwa mosadukiza kamodzi pa sabata , tsiku lomwelo sabata iliyonse. Ndondomeko yowonjezereka ndi:
Masabata 1-4: 0.25 mg
Masabata 5-8: 0.5 mg
Masabata 9-12: 1 mg
Masabata 13-16: 1.7 mg
Mlungu wa 17 kupita patsogolo: kukonza kwa 2.4 mg (ovomerezeka) kapena 1.7 mg
Chizindikiro chamakono cha US chimalolanso akuluakulu omwe alekerera 2.4 mg kwa masabata osachepera a 4 kuti awonjezere kufika pa 7.2 mg mlungu uliwonse pamene kuchepetsa kulemera kumasonyezedwa. Mlingo ndi mphamvu zomwe zilipo zimasiyana malinga ndi mayiko, choncho nthawi zonse tsatirani chizindikiro chapafupi. Kuti mudziwe zambiri za momwe semaglutide imagwirira ntchito, werengani Kumvetsetsa jekeseni wa Semaglutide ndi Ntchito Zake.
Momwe Mungasinthire Kuchokera ku Saxenda kupita ku Wegovy: Gawo ndi Gawo
Palibe chizindikiro cha Wegovy kapena Saxenda chomwe chili ndi protocol yosinthira ya Saxenda-to-Wegovy. Zomwe zikutsatira zikuwonetsa malangizo azachipatala omwe adasindikizidwa komanso machitidwe wamba. Wolembera nthawi zonse amapanga kuyitana komaliza.
Gawo 1: Onaninso Chifukwa Chosinthira
Madokotala amatsimikizira poyamba chifukwa chake wodwalayo akufuna kusintha, kaya ndi mphamvu, zosavuta, mtengo kapena zotsatira zake. Pambuyo pake, amayesanso contraindications. Wegovy sayenera kugwiritsidwa ntchito kwa odwala omwe ali ndi mbiri yakale ya medullary thyroid carcinoma kapena MEN 2, ndipo anthu omwe ali ndi matenda amtundu wa 2 amafunikira kuwunika shuga pakusintha.
Khwerero 2: Nthawi - Palibe Kusamba Kofunikira
Malangizo othandiza omwe adasindikizidwa mu Clinical Diabetes (Almandoz, Lingvay ndi Morales, 2020) akuwonetsa kuti wodwala yemwe amalekerera agonist a GLP-1 tsiku lililonse pa mlingo wathunthu amatha kuyambitsa wothandizira mlungu ndi mlungu tsiku lotsatira mlingo womaliza watsiku ndi tsiku . New Zealand's Christchurch Medicines Information Service (2025) ikunenanso kuti palibe nthawi yochapira yomwe ikufunika. Kumwa mankhwala onse pamodzi sikuvomerezeka pansi pa chizindikiro chilichonse.
Pali chinthu chimodzi chokha. Ngati kusinthaku kumachitika chifukwa cha zotsatira za m'mimba, malangizo omwewo amalangiza kuyimitsa Saxenda ndikudikirira mpaka zizindikirozo zitatha musanayambe Wegovy pa mlingo wotsika kwambiri.
Mseru, kutsekula m'mimba, kusanza ndi kudzimbidwa ndizo zotsatira zoyipa za mankhwalawa. Mu STEP 8, zochitika zam'mimba zidanenedwa ndi 84.1% ya ogwiritsa ntchito semaglutide ndi 82.7% ya ogwiritsa ntchito liraglutide, makamaka ofatsa mpaka ochepa. Komabe, ochepa omwe adatenga nawo gawo adasiya semaglutide (13.5%) kuposa liraglutide (27.6%). Zakudya zazing'ono, kusiya kudya mutakhuta ndikukhalabe ndi hydrate kumathandiza odwala ambiri pa sitepe iliyonse yatsopano ya mlingo.
Njira Yochepetsera Kuwonda
Chifukwa mlingo woyambira wa Wegovy ndi wochepa, odwala ena amazindikira kuyambiranso pang'ono kwa njala m'masabata oyamba atasiya 3 mg Saxenda. Izi nthawi zambiri zimakhazikika pamene mlingo ukukwera. Mu STEP 8, 70.9% ya omwe adatenga nawo gawo pa semaglutide adakwanitsa kuchepa thupi ndi 10% poyerekeza ndi 25.6% pa liraglutide. Zotsatira zimadalirabe zakudya, zochita ndi biology payekha.
Kusintha Kwa nkhope ndi Thupi
Mofulumira, kuonda kwambiri kumatha kuwulula kutayika kwa voliyumu m'makachisi, masaya ndi nsagwada, zomwe zimatchedwa 'Nkhope ya Ozempic'. Zipatala zodzikongoletsa zikuchulukirachulukira kuphatikizira odwala owongolera kulemera ndi machiritso obwezeretsa. Nkhani yathu Kodi Zodzaza Ma Dermal Zingasinthe Nkhope ya Ozempic? Zomwe Zimayambitsa ndi Njira Zochizira zimafotokoza zomwe mungachite.
Zolakwa Zomwe Zimachitika Mukasintha Kuchokera ku Saxenda kupita ku Wegovy
Kuphatikiza mankhwala awiriwa. Osatenga mlingo womaliza wa Saxenda tsiku lomwelo monga jakisoni woyamba wa Wegovy.
Kudumpha molunjika mpaka 2.4 mg. Kudumpha titration kumawonjezera chiopsezo cha zovuta za GI komanso kuwonongeka kwa impso komwe kumakhudzana ndi kuchepa kwa madzi m'thupi.
Kutenga mlingo mofanana. 3 mg ya liraglutide si 'yofanana' ndi mlingo uliwonse wa semaglutide.
Kunyalanyaza mankhwala a shuga. Odwala omwe ali ndi insulin kapena sulfonylureas angafunike kusintha mlingo kuti apewe hypoglycemia.
Kugwiritsa ntchito zinthu za 'semaglutide' zosayendetsedwa. Odwala ayenera kugwiritsa ntchito mankhwala ovomerezeka okha, omwe amaperekedwa ku pharmacies ovomerezeka.
Izi Zikutanthauza Chiyani kwa Zipatala ndi Ogawa
Kwa zipatala zokongoletsa ndi thanzi, kukwera kwa chithandizo cha GLP-1 sabata iliyonse ndikukonzanso maulendo a odwala. Odwala omwe ali ndi vuto la kulemera kwachipatala nthawi zambiri amafunafuna chithandizo chowongolera thupi, kuwongolera khungu komanso kubwezeretsa mphamvu panthawi ya pulogalamu yawo kapena pambuyo pake. Chidule chathu cha Mawonekedwe Apamwamba Opanda Opaleshoni Yathupi ndi Kuwongolera Kulemera kwa mamapu a 2026 komwe kufunikira kukuyenda.
Ogulitsa ndi ogulitsa omwe akumanga malo owongolera kulemera ayenera kuphatikiza chisamaliro cha GLP-1 choperekedwa ndi dokotala, chomwe chizikhala moyang'aniridwa ndi achipatala, chokhala ndi zinthu zovomerezeka monga zodzaza, zolimbikitsa za collagen, mesotherapy ndi jekeseni wozungulira thupi. Kuti mumvetse momwe maubwenzi achinsinsi amagwirira ntchito, werengani Kuwunika Majekeseni Ochepetsa Kulemera kwa OEM: Mwayi Wanzeru Wamabizinesi Aumoyo ndi Ubwino . AOMA imathandizira othandizana nawo omwe amapanga GMP, zolemba zowongolera komanso kuyika chizindikiro.
FAQ
Kodi ndingayambitse Wegovy tsiku lotsatira jakisoni wanga womaliza wa Saxenda?
Nthawi zambiri, inde. Upangiri wosindikizidwa umanena kuti palibe kuchapa kumafunika, ndipo wothandizira mlungu uliwonse akhoza kuyamba tsiku lotsatira mlingo womaliza wa tsiku ndi tsiku. Ngati mukusintha chifukwa cha zotsatirapo, dokotala wanu angakufunseni kuti mudikire mpaka zizindikirozo zitatha.
Ndi mlingo wanji wa Wegovy womwe ndiyenera kuyamba nawo pambuyo pa Saxenda 3 mg?
Chizindikiro cha Wegovy chimayamba aliyense pa 0.25 mg sabata iliyonse. Zithandizo zina zachipatala zimawona kuti 0,5 mg yochotsedwa kwa odwala osakhazikika pa Saxenda 3 mg. Wolembera wanu amasankha malinga ndi kulolera kwanu.
Mu STEP 8 mutu-to-head trial, semaglutide 2.4 mg inapanga pafupifupi 15.8% kulemera kwa thupi ndi 6.4% ndi liraglutide 3.0 mg pa masabata a 68. Zotsatira zimasiyana.
Medical Chodzikanira
Nkhaniyi ndi yophunzitsa anthu wamba komanso akatswiri azachipatala komanso akatswiri am'makampani. Si malangizo achipatala. Saxenda ndi Wegovy ndi mankhwala omwe amangoperekedwa ndi dokotala. Kusintha kulikonse kwamankhwala, kuphatikiza nthawi ndi madontho, kuyenera kugamulidwa ndi wolembera yemwe ali ndi chilolezo molingana ndi zomwe akulembera. AOMA sipanga kapena kugulitsa Saxenda kapena Wegovy, zomwe ndi zizindikilo za Novo Nordisk A/S.
Maumboni
Rubino DM, Greenway FL, Khalid U, et al. Zotsatira za mlungu uliwonse subcutaneous semaglutide vs tsiku ndi tsiku liraglutide pa kulemera kwa thupi kwa akuluakulu omwe ali ndi kunenepa kwambiri kapena onenepa kwambiri opanda matenda a shuga: STEP 8 randomized clinical trial. JAMA . 2022;327(2):138-150. PMID: 35015037.
Almandoz JP, Lingvay I, Morales J, et al. Kusintha pakati pa glucagon-ngati peptide-1 receptor agonists: zomveka komanso malangizo othandiza. Clin Diabetes . 2020; 38(4):390-402. PMID: 33132510.
WEGOVY (semaglutide) jakisoni / mapiritsi, US Prescribing Information, Novo Nordisk (DailyMed, yasinthidwa June 2026).
Jakisoni wa SAXENDA (liraglutide), US Prescribing Information, Novo Nordisk (DailyMed / FDA, 2026).
US Department of Veterans Affairs. Semaglutide (WEGOVY) subcutaneous jakisoni wowongolera pakuwongolera kulemera, February 2023.
Christchurch Medicines Information Service. Kusintha kuchokera ku liraglutide (Saxenda) kupita ku semaglutide (Wegovy), Julayi 2025.
Dr. Emily Carter (MD, Fellow of the American Academy of Dermatology) ndi dotolo wodziwika bwino wa zodzikongoletsera ku New York City yemwe ali ndi zaka zopitilira 9 wodziwa ntchito za hyaluronic acid fillers, kuchiza ziphuphu zakumaso, komanso kuyang'ana pang'ono kumaso. Amadziwika makamaka chifukwa cha ukatswiri wake pamankhwala apamwamba obaya omwe amachepetsa zipsera, amalimbikitsa machiritso a khungu, ndikubwezeretsa kusalala kudzera mu jakisoni wokonzanso khungu ndi njira zolimbikitsira khungu.
